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Abstract
The purpose of this report is to apply multi-scale modeling using the theory of physiologically
structured populations (PSP) to develop a mathematical model for antimicrobial resistance
based on a heterogeneous distribution of receptors and affinities among bacterial cells. The
theory has been tested on data obtained from an in vitro static time-kill infection model ana-
lyzing the pharmacodynamics of polymyxin B against Gram-negative bacteria. The drug
binding parameter KD (dissociation equilibrium constant) is assumed to vary between the
bacterial cells. The PSP model describes the time course of the density distribution of KD
upon exposure to cytotoxic drug concentrations. The drug increases the hazard of cell death
as a function of receptor occupancy. The initial distribution of KD is described by the Weibull
function. Time-kill data were used for model qualification. In vitro static time-kill experiments
to evaluate the rate and extent of killing due to polymyxin B against two Klebsiella pneumo-
niae clinical isolates with differing susceptibilities to polymyxin B were performed over 48 h.
The time-kill kinetics data of bacterial load cfu (colony forming units)/mL was used for model
qualification. The resistant bacterial population is determined by the balance between
growth rate and hazard of cell death controlled by polymyxin B concentrations. There exists
a critical KD value below which cells continue to grow. Estimates of shape parameters for
distributions of KD yielded unimodal distributions with the modes at 0 nM and the right tails
containing approximately 25% of the bacteria. Our findings support a hypothesis that resis-
tance of Klebsiella pneumoniae to polymyxin B can be at least partially attributed to a drug-
induced selection of a subpopulation due to heterogeneity of polymyxin B receptor binding
in the bacterial population.
Introduction
Prevalence of Gram-negative bacteria resistant to almost all currently available antibiotics is
rapidly escalating at an alarming rate. This poses a serious clinical challenge as it limits our
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treatment options against infections due to resistant Gram-negative pathogens. Mechanisms
of bacterial resistance have been classified into three categories: intrinsic, acquired, and adap-
tive [1]. Intrinsic resistance comprises all the inherent mechanisms that restrain the effects of
antimicrobials by reducing the intracellular drug concentration (such as Gram-negative outer
membrane that is impermeable to several antimicrobial classes and the increased expression of
numerous efflux pumps). Acquired resistance refers to the acquisition of new genes by the
incorporation of genetic material or a result of spontaneous mutations enabling bacteria to
withstand higher antibiotic concentrations. Adaptive resistance is a temporary increase in the
ability of bacteria to survive drug pressure with alterations to the gene and/or protein expres-
sion in response to the environmental trigger. Adaptive resistance, in contrast to intrinsic or
acquired resistance, is triggered in response to the selective pressure exerted by the use of anti-
biotics. Bacterial phenotype can contain a high degree of molecular heterogeneity. An example
of adaptive drug resistance is a drug-induced selection of a resistant bacterial subpopulation
that were present in the original bacterial population [2].
Polymyxin B is a polycationic cyclic antimicrobial peptide with a molecular mass 1,200 Da
carrying five positively charged residues of diaminobutyric acid. Polymyxin B binds to lipo-
polysaccharide (LPS) expressed on the outer membrane of Gram-negative bacteria such as
Escherichia coli and Klebsiella pneumoniae by displacing divalent cations Mg2+ and Ca2+ that
cross-bridge between adjacent negatively charged phosphate groups [3]. Upon biding to LPS,
polymyxin B forms a complex with LPS that penetrates the outer membrane of the bacteria.
The bactericidal effect of polymyxin B is attributed to its interaction with the cytoplasmic
membrane that alters its functions such as active transport and respiration [4].
Gram-negative bacteria alter their LPSs to protect themselves against the bactericidal effects
of polymyxin B. One of the most common modifications of LPS resulting in reduced binding
affinity to polymyxin is the cationic substitution of its phosphate groups by 4-amino-4-deoxy-
L-arabinose (L-Ara4N) causing a decrease in the net negative charge of lipid A, a constituent
moiety of LPS [5–6] and hence resulting in resistance to polymyxin B. The other common
method resulting in the modification of lipid A, is the addition of phosphoethanolamine
(PEtN) resulting in a decrease in the net negative charge causing a shift towards cationicity
with decreased binding affinity for polymyxin B, resulting in eventual resistance to polymyxins
[5–6]. The synthesis and transfer of L-Ara4N and PEtN to lipid A resulting in polymyxin resis-
tance is triggered by the activation of PhoP/PhoQ and PmrA/PmrB, the two-component
systems (TCS) due to environmental stimuli like drug concentrations, changes in growth con-
ditions or specific mutations occurring within TCS will result in the upregulation of operons
that facilitate [6–8].
Most of the mathematical models to date describe the emergence of resistance in response
to drug pressure as a mixture of bacterial subpopulations with differing degrees of antibiotic
susceptibilities [9–10]. Drug effects depend on the degree of susceptibility of the bacterial
subpopulations, and the composition of the total bacterial population exposed to the drug con-
centration can change over time as bacterial subpopulations which are less susceptible can
become dominant. Such models typically assume acquired resistance due to bacterial muta-
tions which determine the initial (prior to drug treatment) partition of the total bacterial popu-
lation into susceptible subpopulations.
Physiologically structured population (PSP) models were first introduced in ecology to
describe the behavior of a population of individual organisms sharing and interacting in a
common environment [11]. A key concept of structure as the unique subject characteristics
can be extended to cell protein expression, DNA, and RNA content [12–13]. A PSP model
describes dynamics of a structure within a bacterium and quantifies its distribution within the
bacterial population. The environment can affect both a bacterium and the entire bacterial
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population. For describing in vitro bacteria, the growth media constitutes the environment. In
particular, the drug concentration is the most relevant environmental variable determining the
dynamics of bacterial population. In the context of Gram-negative bacteria resistance to poly-
myxin B, a structure of interest will be the expression of LPS on the outer membrane. PSP
models are designed to quantify heterogeneity of the bacterial structure and the impact of the
environment on the dynamics of bacterial populations.
Our leading hypothesis is that resistance of Klebsiella pneumoniae to polymyxin B can be at
least partially attributed to a drug-induced selection of a subpopulation due to the heterogene-
ity of LPS binding in the bacterial population. We apply a PSP model to describe the time-kill
kinetics data for two clinical strains with differing susceptibilities to polymyxin B with infor-
mation regarding the distribution of binding affinities, maximal efficacies, and critical concen-
trations of polymyxin B necessary for the emergence of resistant bacterial subpopulations.
First, we briefly introduce a general framework for PSP models. Next we apply the pharmaco-
logical principles of receptor occupancy to introduce binding structures and define the bacteri-
cidal effect of the drug. The resulting model is fitted to the experimental time-kill kinetics data
and furthermore the parameter estimates were used to simulate the process of selection of
resistant subpopulations by exposure to the drug.
Materials and methods
In vitro static time-kill study
Klebsiella pneumoniae Carbapenemase (KPC) producing Klebsiella pneumoniae clinical strains
BAA1705™ (obtained from ATCC1) and KP619 (obtained from a patient treated for bacterae-
mia at the Kingman Regional Medical Center, Kingman, Arizona) were used. MICs (mini-
mum inhibitory concentrations) were determined in triplicate by broth microdilution as per
the Clinical and Laboratory Standards Institute guidelines (Clinical and Laboratory Standards
Institute. 2014. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-
Fourth Informational Supplement. CLSI document M100-S24. Clinical and Laboratory Stan-
dards Institute, Wayne, PA).
Mueller-Hinton broth (Becton, Dickinson and Company, Sparks, MD) supplemented with
calcium and magnesium (CAMHB; 25.0mg/L Ca2+, 12.5mg/L Mg2+) was used for susceptibil-
ity testing and in vitro time-kill models. Stock solutions of polymyxin B (Sigma-Aldrich,
St. Louis, MO, Lot. WXBB4470V) were freshly prepared in sterile water prior to each experi-
ment. All drug solutions were filter sterilized using a 0.22μm filter (Fisher Scientific). Static
time-kill experiments were performed over 48 h to evaluate pharmacodynamic activity of poly-
myxin B monotherapy against the two K. pneumoniae clinical strains. The rate and extent of
killing polymyxin B 0.5, 1, 2, 4, 8, and 16 mg/L was assessed. Polymyxin B was added to the
logarithmic-phase broth culture prepared prior to each experiment by adding fresh bacterial
colonies from overnight growth to pre-warmed CAMHB (37˚C) to achieve the desired initial
inoculum of ~106 cfu/mL. Serial samples were obtained at 0, 1, 2, 4, 6, 8, 24, 28, 32, and 48 h
for bacterial quantification.
PSP model
PSP models were originally introduced to describe dynamics of population of animals in their
habitat [11,14]. However, the theoretical framework applies to any population of individuals
living in a specific environment. A PSP model describes the dynamics of a population in terms
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of the behavior of its constituent individuals. It consists of i-state equations:
dx
dt
¼ gðE; xÞ; t > 0; x 2 O ð1Þ
where x is an n-dimensional vector of individual structures (i-state), O is the space containing
all individual states, and E is a vector of environmental variables influencing individual states
that is described by e-state equations:
dE
dt
¼ f ðE;cðnð; tÞÞ; tÞ; t > 0 ð2Þ
where n(x, t) is the density distribution of the structure x at time t (p-state) and C(n(, t)) is a
population characteristic (e.g. population size) defined by the p-state. For example, by defini-
tion of the density function, the number of subjects in the population at time t is
NðtÞ ¼
Z
O
nðx; tÞdx ð3Þ
P-state equations are central for the PSP model:
@nðx; tÞ
@t
þ divðgðE; xÞnðx; tÞÞ ¼ lðE;Cðnð; tÞ; x; tÞÞ   mðE;Cðnð; tÞ; xÞÞnðx; tÞ; t > 0; x 2 O ð4Þ
where λ(E, C(n(, t), x, t)) is the density of production rate and μ(E, C(n(, t), x)) is the mortal-
ity rate, for individuals of structure x. The p-state Eq (4) uniquely defines the density n(x, t) if
boundary and initial conditions are specified:
vðxÞ  gðE; xÞnðx; tÞ ¼ aðx; tÞ; t > 0; x  @O ð5Þ
and
Eð0Þ ¼ E0; nðx; 0Þ ¼ n0ðxÞ; x  O ð6Þ
where υ(x) is the unit inward-pointing normal vector at x @O, and α(x, t) and n0(x) are
known functions.
Binding-structured population models of bacteria in vitro. We will consider bacteria
growing in the in vitro static time-kill model to be exposed to a polymyxin B concentration of
C. The drug concentration constitutes an environmental variable (e-state) that affect the status
of each bacterium. Since polymyxin B is stable and the degradation is minimal for the duration
of the experiment, we assume that drug concentration in the medium does not change over
time:
dC
dt
¼ 0 ð7Þ
Eq (7) is an analog of the e-state Eq (2). Based on the pharmacological principles of drug-
receptor theory, the drug effect on each bacterium is determined by the number of receptors
bound to the drug (b) [15]. The number of bound receptors b depends on the drug concentra-
tion in medium C and the number of free receptors per bacterium r, and the number of bacte-
ria N in the culture. Since the time scale for binding and receptor turnover is much smaller as
compared to the time scale for the growth of bacteria we assume that the binding is at dynamic
equilibrium. Then the bound receptor on each cell can be calculated as
b ¼
rtotC
KD þ C
ð8Þ
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where KD is the equilibrium disassociation constant and rtot describes the total number of
receptors per bacterium that is assumed to be constant:
rtot ¼ r þ b ð9Þ
Consequently, under equilibrium assumptions, we get r ¼ rtotKDKDþC, hence the number of free
and bound receptors on a bacterial cell is determined by rtot and KD specific for that cell. In
this context, a relevant structure determining the status of each bacterium is a vector (rtot, KD).
In this section we have x = (rtot, KD) and E = C. Since the bacterial cell binding parameters
are constant, the i-state Eq (1) becomes:
d
dt
ðrtot;KDÞ ¼ ð0; 0Þ ¼ gðC; rtot;KDÞ ð10Þ
Under these assumptions the p-state Eq (4) describing the receptor density n(rtot, KD, t)
simplifies to
@nðrtot;KD; tÞ
@t
¼ lðC; N; rtot;KD; tÞ   mðC; N; rtot;KDÞnðrtot;KD; tÞ; rtot > 0; KD > 0; t > 0 ð11Þ
with the initial condition
nðrtot;KD; 0Þ ¼ n0ðrtot;KDÞ; rtot > 0; KD > 0 ð12Þ
Cytotoxic effect. The mortality rate μ(C, N, rtot, KD) is assumed to be independent of the
bacteria population size and is stimulated by the drug:
mðC;N; rtot;KDÞ ¼ m0SðbÞ ð13Þ
where μ0 is the first-order death rate constant and S(b) is the stimulatory function. We assume
that the drug effects are characterized as power functions of b
SðbÞ ¼ 1þ kbg ð14Þ
where γ is the power coefficient describing the steepness of the stimulatory curve and κ is the
coefficient.
Modeling bacteria growth. To accurately describe the dynamics of bacteria growth in
vitro we will adopt existing models [16]. The bacterial density growth rate λ(C, N, rtot, KD) is
assumed to slow down with an increasing bacteria population size:
lðC; N; rtot;KD; tÞ ¼
VGmax
Nm þ N
nðrtot;KD; tÞ ð15Þ
where VGmax is a maximal velocity of bacterial growth, and Nm denotes the bacterial count
that results in 50% of the maximal rate of growth. If the size of the bacteria population is much
less than Nm i.e.
N  Nm ð16Þ
then the growth rate becomes linear:
lðC;N; rtot;KD; tÞ ¼ l0nðrtot;KD; tÞ ð17Þ
Multi-scale model for adaptive bacterial resistance to polymyxin B
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where λ0 = VGmax/Nm. Integrating p-state Eq (11) one can arrive at a solution:
nðrtot;KD; tÞ ¼ n0ðrtot;KDÞexpððl0   m0SðbÞÞtÞ ð18Þ
Where bound receptor b is determined by Eq (8). In the case of point distribution of
rtot rtot0:
nðKD; tÞ ¼ n0ðKDÞexpððl0   m0SðbÞÞtÞ ð19Þ
where
n0ðKDÞ ¼ N0
b
a
KD
a
 b  1
exp  
KD
a
 b
 !
ð20Þ
Cell count response. The bacterial cell count in the population can be calculated by inte-
gration of the density n(rtot, KD, t) as shown in Eq (3). Integrating of Eq (18) over rtot and KD
yields:
NðtÞ ¼
Z 1
0
Z 1
0
n0ðrtot;KDÞexpððl0   m0SðbÞÞtÞd rtotd KD ð21Þ
In the absence of the drug (S(b) 1) the bacteria population grows exponentially:
NðtÞ ¼ N0expððl0   m0ÞtÞ ð22Þ
with the half-life
t1=2 ¼
lnð2Þ
l0   m0
ð23Þ
In the case of point distribution of rtot rtot0:
NðtÞ ¼
Z 1
0
n0ðKDÞexp ðl0   m0S
rtot0C
KD þ C
 
Þt
 
d KD ð24Þ
whereas all cells have the same affinity KD KD0:
NðtÞ ¼
Z 1
0
n0ðrtotÞexp ðl0   m0S
rtotC
KD0 þ C
 
Þt
 
d rtot ð25Þ
Initial distribution of rtot and KD. The last part of the model to be defined is the initial
density of rtot and KD. Anticipating limited information from in vitro bacteria growth data
about the expression of receptors and bacteria affinities to drug, a parsimonious approach was
taken to describe n0(rtot, KD). A natural assumption is independence of rtot and KD distribu-
tions resulting in the product:
n0ðrtot;KDÞ ¼ N0p0ðrtotÞq0ðKDÞ ð26Þ
where p0(rtot) and q0(KD) are probability density functions (pdfs) for rtot and KD distributions,
respectively. Two type of pdfs were tested to account for extreme cases: Weibull
pðxÞ ¼
b
a
x
a
 b  1
exp  
x
a
 b
 
ð27Þ
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where α is the scale parameter and β is the shape parameter, and point distribution
pðxÞ ¼ dðx   x0Þ ð28Þ
where x0 is the center of the distribution. The point distribution assumes all cells have the
same structure value (rtot or KD).
Data analysis
The model parameters were estimated using the SAEM algorithm implemented in Monolix
4.3.3 (Lixoft). Simulations were prformed in MATLAB (R2013a, MathWorks). The numeri-
cal evaluation of the integrals was done by the MATLAB function integral available to
Monolix.
Results
Mechanisms of resistance for bacterial population with unrestricted
growth
The binding-structured population model offers an explanation for a mechanism of resistance
of bacteria in response to treatment with a bactericidal antibiotic based on the balance between
production and elimination rates that can vary between bacteria as a consequence of bacteria
specific binding of the drug. For the unrestricted growth of bacteria, the time course of the
density function n(rtot, KD, t) is described by the p-state equation:
@nðrtot;KD; tÞ
@t
¼ ðl0   m0SðbÞÞnðrtot;KD; tÞ ð29Þ
which can be solved to yield Eq (11). Consequently, the curve
l0   m0SðbÞ ¼ 0 ð30Þ
divides the plane (rtot, KD) into two regions. Bacteria in the region for which the left hand side
of Eq (30) is negative will exponentially die, whereas bacteria in the complementary region will
grow exponentially. This is a resistance mechanism where the drug selects bacteria in the initial
bacterial population n0(rtot, KD, t) for death or survival depending on their binding characteris-
tics [2]. Bacteria expressing large number of receptors or with strong binding affinity are likely
to die, while the bacteria expressing few receptors or with weak binding affinity for the drug
will survival forming a new more resistant bacterial population growing exponentially in time.
The time for the emergence of this new more resistant bacterial population depends on the
proportion of the initial distribution contained in the growing region of the (rtot, KD) plane.
According to Eq (30) there exists a critical number of bound receptors per bacterium bcrit such
that a subpopulation of bacteria expressing bound receptors b< bcrit will continue to grow.
This happens as the elimination rate of bacteria is determined by the hazard of death which is
less than the production rate of bacteria determined by λ0. While the subpopulation of bacteria
with bound receptors b> bcrit diminishes as the hazard of death is greater than the production
rate of bacteria.
l0 ¼ m0SðbcritÞ ð31Þ
Fig 1 illustrates the balance between the hazard of bacterial death and the first-order pro-
duction that defines the critical number of bound receptors available in the population for the
drug to exert its effect.
Multi-scale model for adaptive bacterial resistance to polymyxin B
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To demonstrate this mechanism we will use an example of bacteria that differ only in terms
of their binding affinity KD while expressing the same number of receptors rtot0. Then a two
dimensional density n(rtot, KD, t) can be reduced to a one dimensional density n(KD, t). Since
the number of bound receptors is uniquely determined by bacteria binding characteristics Eq
(8), there exists a critical equilibrium dissociation constant KDcrit such that a subpopulation of
bacteria with KD> KDcrit continue to grow whereas a subpopulation of bacteria KD< KDcrit are
decreasing:
KDcrit ¼ C
m0krtot0g
l0   m0
 1=g
  1
 !
ð32Þ
Eq (32) implies that necessary and sufficient condition for existence of bacteria as KDcrit is
krtot0
g >
l0
m0
  1 > 0 ð33Þ
Fig 1. The mortality rate as a function of the number bound receptors per cell. The hazard of cell removal μ0S(b)
increases as an effect of drug action S(b) starting from the baseline value μ0. The horizontal line marks the first-order
production rate constant for cell population λ0. The interception of two lines determines the critical value of bound receptors
bcrit. Cells with b < bcrit will continue to grow whereas cells bcrit < b are destin to die.
https://doi.org/10.1371/journal.pone.0171834.g001
Multi-scale model for adaptive bacterial resistance to polymyxin B
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In particular, Eq (33) implies that if bacteria express a low number of receptors, then KDcrit
may not exist and the original bacteria population will continue to grow exponentially, entirely
resistant to drug effect.
Resistance of Gram-negative bacteria to polymyxin B
Two clinical strains of KPC producing Klebsiella pneumoniae with differing susceptibilities to
polymyxin B were grown in Mueller Hinton broth, growth media containing escalating poly-
myxin B concentrations over 48 h. For the susceptible strain BAA1705 the minimum inhibi-
tory concentration (MIC) for polymyxin B is 0.5 mg/L whereas for the more resistant strain
KP619 MIC for polymyxin B is 64 mg/L. Time-kill kinetics for both strains are shown in Fig 2.
In time-kill studies, polymyxin B was bactericidal in a concentration-dependent manner Fig 2.
All polymyxin B concentrations evaluated resulted in a >3 log10 reduction against BAA1705
by 2–4 h and all strains regrew until they were similar to growth control or until they reached
the threshold. Against KP619, a less than 1-log10 reduction was seen at concentrations greater
than 4 mg/L that was not sustained beyond 4 h and regrowth was seen at all evaluated concen-
trations. To ensure exponential growth the control data were used to determine a threshold of
108 cfu/mL to censor the data for all treatment groups when the size of the bacteria population
increases above the threshold. The rate (or initial slope of time-kill curves) was greater and
extent of killing by polymyxin B for BAA1705 was more extensive as compared to that for
KP619, consistent with their reported polymyxin B susceptibilities. The time-kill data imply
the emergence of bacteria resistant to polymyxin beyond 4–6h of exposure to polymyxin B.
According to the assumption of heterogeneity in polymyxin B affinities of the receptors
expressed by the bacteria populations evaluated here, the time-kill kinetics data were fitted by
the model Eq (23). The resulting fits are shown in Fig 2 and parameter estimates and their 95%
CIs are presented in Table 1. Two model parameters could not be estimated based on the avail-
able data and hence they were fixed. The bacterial natural death rate constant (baseline haz-
ard), μ0 was set to the value 0.3 day-1 reported elsewhere [17]. The scale parameter α, for the
initial distribution was set at the value of 380 nM, the equilibrium dissociation constant for
polymyxin B binding to LPS [18]. The estimated shape factors β were< 1 implying right-
skewed distributions with singularity at KD = 0. Since 95% CIs corresponding to BAA1705 and
KP619 strains are disjoint, the KD distributions are significantly different which is confirmed
by Fig 3. The dimensional analysis revealed that parameters κ and rtot0 can be estimated only
as a part of the term vrtot0γ. The latter can be interpreted as the drug effect corresponding to
100% receptor occupancy, a maximal stimulation for the given number of receptors per
bacterium.
Distribution of affinities to polymyxin B
The model structure and parameter estimates allows one to make inferences about the initial
distribution of KD among the bacteria and the shape of the hazard function for escalating drug
concentrations. Fig 3 reveals the inferred KD density distributions after initiating treatment
with polymyxin B against both clinical isolates evaluated. The estimated shape factors β
were< 1 implying right-skewed distributions with singularity at KD = 0. The cumulative dis-
tribution functions yield the following quartiles Q1 = 1.06 nM, Q2 = 67 nM, and Q3 = 1788 nM
(BAA1705), and Q1 = 17.4 nM, Q2 = 154 nM, and Q3 = 853 nM (K619). This implies that
more than half of both bacterial isolates have stronger affinity for polymyxin B than reported
380 nM. Also, about quarter of the bacteria bind to polymyxin B in the micro molar range. As
expected, BAA1705 isolate has more polymyxin B susceptible bacteria with KD< 100 nM as
compared to the more resistant KP619 isolate (53% vs. 44%).
Multi-scale model for adaptive bacterial resistance to polymyxin B
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Fig 2. Time-kill data for BAA1709 (upper panel) and KP619 (lower panel) strain. Symbols represent the
measurements and lines are model fitted curves. The dashed line marks the limit of quantification of 1 cfu/mL.
The triangle symbols are measurements below limit of quantification.
https://doi.org/10.1371/journal.pone.0171834.g002
Multi-scale model for adaptive bacterial resistance to polymyxin B
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Cytotoxic effect of polymyxin B
The estimates of γ and κrtot0γ are sufficient to generate plots of the hazard μ0S(b) as functions
KD shown in Fig 4:
m0SðbÞ ¼ m0 1þ krtot0
g C
KD þ C
 g 
ð34Þ
At KD = 0 nM the maximum hazards of bacteria death were 18.7 day-1 and 3.3 day-1 for
BAA1705 and KP619, respectively. The hazards decreased with increasing KD and were depen-
dent on the polymyxin B concentration. Higher polymyxin B concentrations resulted in higher
hazards of death. The sensitivity of the hazard to drug concentration was higher for BAA1705
compared to that for KP619, consistent with values of γ parameter as the power of the receptor
occupancy C/(KD + C).
Selection of resistant cell population
The affinity of bacteria to polymyxin B, KDcrit determines its fate, when it is exposed to the
cytotoxic effect of drug. Bacteria with KD> KDcrit will grow, whereas bacteria with KD< KDcrit
are destined to be killed by the drug. This is the basic mechanism of selection for resistant bac-
teria based on their affinity to drug. Fig 5 shows the density n(KD, t) at various times for KP619
exposed to polymyxin B concentration of C = 8 mg/L to illustrate the emergence of resistant
bacteria subpopulation with KD> KDcrit = 6003 nM. At time t = 0 h, only 4.7% of N(0) = 1.2
x106 cfu/mL bacteria had KD> KDcrit. At t = 2 h, this fraction increased to 52.7% of N(2) = 3.2
x105 cfu/mL, and by t = 4 h almost the entire bacteria population 95.5% of N(4) = 9.1x105 cfu/
mL became resistant, and the process of growth dominated the killing. At t = 8 h more than
99.9% of N(8) = 7.8 x107 cfu/mL bacteria had KD> KDcrit, and consequently the population
size increased exponentially with time. This suggests that bacteria with weak binding affinity
to the drug become resistant, while bacteria with strong binding affinity to the drug are elimi-
nated. Another observation is that the drug concentration, C is also a determinant of the
emergence of resistant bacterial population. The time scale for emergence of the resistant pop-
ulation depends on the percentile of the initial distribution cut off by KDcrit. The smaller the
tail is, the longer it takes for the resistant bacteria population to emerge. Lastly, over time as
the total bacteria population becomes resistant, the KD values shifts to higher values or KD. val-
ues tend to increase. The mode at t = 8 h was 40,306 nM whereas at t = 10 h it was 51,042 nM.
The process of selection resistant population for BAA1705 strain was qualitatively similar to
that for KP619 strain.
Table 1. Parameter estimates of model Eq (24) obtained by fitting the time-kill data for BAA1705 and KP619 strains shown in Fig 2.
Parameter Estimate (%RSE) BAA1705 95% CI BAA1705 Estimate (%RSE) KP619 95% CI KP619
λ0, day-1 3.27 (22) [1.80,4.74] 2.02 (9) [1.63;2.41]
μ0, day-1 0.3* 0.3*
κrtot0
γ 61.2 (35) [18.4,104.0] 10.1 (8) [8.34,11.6]
γ 0.186 (32) [0.0657,0.306] 0.831 (29) [0.335,1.33]
log10N0, cfu/mL 5.92 (5) [5.35,6.49] 6.07 (1) [5.93,6.21]
α, nM 380* 380*
β 0.211 (13) [0.154,0.268] 0.404 (9) [0.334,0.474]
%RSE stands for percent relative standard error of the estimate.
*—parameter was fixed.
https://doi.org/10.1371/journal.pone.0171834.t001
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Discussion
Existing in vitro models of infection account for resistance in response to drug pressure by
describing the total bacterial population by considering a discrete number of bacterial subpop-
ulations with varying degrees of susceptibility to the antibiotic(s) being evaluated (see for
example [9]). The approach presented here fundamentally differs from assuming a priori
existence of several bacterial subpopulations as opposed to one that evolves in time upon expo-
sure to drug resulting in the emergence of a resistant population eventually. The discrete sus-
ceptibilities of bacteria to drug is explained by a continuous distribution of drug binding
Fig 3. Initial KD density distributions (upper panel) and cumulative distribution functions (lower
panel) for BAA1705 and KP619 strains. Estimated parameter values from Table 1 were used to simulate
n0(KD) and corresponding cdfs based on Eq (20).
https://doi.org/10.1371/journal.pone.0171834.g003
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characteristics within the bacterial population. A resistant population is determined by the bal-
ance between the growth and death processes altered by the drug. As such, the distribution
will change in time where the concentration of the drug is the forcing function.
Since resistance emerges at low bacteria counts, our model of bacteria growth was limited
to a first-order process with drug stimulating bacterial death. This simplification was inten-
tional to arrive at a mathematically simpler model allowing for explicit criteria determining
the critical binding characteristics necessary to define a resistant bacteria population. Conse-
quently, the model can be applied to the time-kill kinetics data only within the exponential
growth phase. Given the two characteristics of receptor density, rtot and affinity for drug, KD,
the model was further simplified by assuming that these characteristics do not vary between
bacteria. This was necessary since the available data did not support identifiability of these
parameters for a two-dimensional distribution. The model allowed for a rather flexible initial
distribution of binding characteristics (Weibull function), and a relatively general model of the
effect of the drug on the hazard of cell death (power function of bound receptors per cell).
The model was qualified against time-kill kinetics data for two isolates of KPC producing
Klebsiella Pneumoniae with differing susceptibilities to polymyxin B with the assumption of
the same target expression within the bacterial population. Parameter estimates revealed simi-
lar qualitative characteristics but difference in numerical values. The initial distributions of KD
for both strains were centered near the vicinity of KD = 0 with right tails extending to infinity
with about 25% of bacteria in the micro-molar range. The drug effect on the death hazard
differed in its maximal value being 6-fold stronger for the more susceptible bacteria strain,
Fig 4. Hazard as functions of KD for BAA1709 and KP619 strains. The curves μ0S(b) vs. KD were simulated
using Eq (34) for indicated drug concentrations. Parameter values used for simulations are presented in Table 1.
https://doi.org/10.1371/journal.pone.0171834.g004
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BAA1705. Also, the sensitivity of the more susceptible bacteria strain to drug concentration
was higher.
The selection of functions describing initial distributions of target within the bacteria popu-
lation and drug effects on the death hazard was parsimonious. While the Weibull probability
density function guaranteed sufficient flexibility, a scale parameter could not be identified. The
power function Eq (20) for describing the drug effect was a reduced form of the sigmoidal
Emax model recommended by the operational model of agonism [19]. Such an extension
would allow for maximal saturation of the bacteria killing when the number of bound recep-
tors per bacterium is high. This feature might be of importance for selection resistance mecha-
nisms due to the distribution of rtot within the population which have not been explored in
Fig 5. Simulated density distributions of KD at various times for KP619 bacteria population exposed
to polymyxin B concentration of C = 8 mg/L. Si The vertical line indicates KDcrit = 6003 nM. The ranges of y
axes were adjusted to best illustrate the shape of distribution. At t = 0 the distribution is equal to the initial
density n0(KD) described by the Weibull distribution Eq (16). As time progresses the density of cells with KD <
KDcrit vanishes whereas cells with KD > KDcrit form a new population that eventually grows exponentially. The
density distribution at KD = KDcrit remains constant.
https://doi.org/10.1371/journal.pone.0171834.g005
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this report. This part of our modeling approach indicates limitation of time-kill kinetics data
in order to make inferences about mechanisms of resistance and drug pharmacodynamics.
Additional information about time courses of receptor expression on bacteria exposed to drug
effect is warranted.
The mathematical framework of structured populations was applied to describe the time
courses of the KD distributions in its simplest form. Constant drug concentrations eliminated
the need of modeling the environment (pharmacokinetic model was absent). However, this
assumption might be violated if the size of bacteria population is large enough to clear drug
from the medium. The assumption of binding equilibrium between drug and receptors yielded
a trivial bacteria level model of the receptor turnover and allowed for introducing KD as a
structure. This limited the mechanism of resistance to a passive selection of bacteria by the
drug based on the distribution of rtot and KD. A more dynamic model (i-state) would allow for
description of additional mechanisms of resistance such as down-regulation of the receptor by
the bacteria in response to environmental triggers.
In summary, we applied a theory of physiologically structured populations to develop a
mathematical model of bacteria resistance to antibiotics in vitro that is based on a heteroge-
neous distribution of receptors and affinities among cells. This model can account for a mech-
anism of resistance due to selection of bacteria with favorable binding characteristics given
particular drug concentration. The model is limited to exponential growth of bacteria with
drug stimulating bacterial killing. The resistant population is determined by the balance
between growth rate and hazard of cell death. Two bacterial isolates with different susceptibili-
ties to polymyxin B were used for model qualification assuming similar receptor expression on
all bacteria. Estimates of shape parameters for distributions of dissociation equilibrium con-
stants yielded unimodal distributions with the modes at 0 nM and the right tails containing
approximately 25% of the bacteria. The maximal efficacy of polymyxin B was about 6-fold
higher for the more susceptible strain than for less susceptible one. Finally, we observed that
the time-kill experimental in vitro data contained limited information about the mechanisms
of resistance and drug pharmacodynamics, implying that additional experimental techniques
using dynamic in vitro models of infection might provide data that would allow for less parsi-
monious models than the one presented here that can be used for analysis.
Appendix
Derivation of Eq (18)
Despite of presence of many variables, the p-state Eq (11) is a linear ODE with respect to time t
that can be solved by the integrating factor method. Under the simplifying conditions Eqs (13)
and (17), the p-state Eq (11) becomes Eq (29). Multiply both sides of Eq (19) by the integrating
factor exp((−λ0 + μ0S(b))t) to arrive at
@
@t
ðnðrtot;KD; tÞexpðð  l0 þ m0SðbÞÞtÞÞ ¼ 0 ð35Þ
Hence, the initial condition Eq (12) implies
nðrtot;KD; tÞexpðð  l0 þ m0SðbÞÞtÞ ¼ n0ðrtot;KDÞ ð36Þ
and Eq (18) follows.
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Supporting information
S1 Data. This is the compressed data file containing the in vitro data for both bacterial
strains used to develop the model.
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